Abstract
Infection of the rhesus monkey with simian immunodeficiency virus of macaques (SIVmax) was employed to explore the early immune events associated with the initial containment of an acute AIDS virus infection. In nine rhesus monkeys infected intravenously with uncloned SIVmac strain 251, high-level p27 plasma antigenemia was usually detected transiently from approximately day 7 through day 21 following virus inoculation. SIVmac replication in lymph nodes measured by in situ RNA hybridization closely paralleled the time course and magnitude of viremia. The containment of SIVmac spread by 3 to 4 weeks following infection suggests an efficient, early immune control of this virus infection. Anti-SIVmac antibodies were first detected in the blood at approximately day 14. At the time antigenemia was decreased or cleared, SIVmac neutralizing antibodies were present. A rise in circulating and lymph node CD8+ T cells also occurred coincident with the clearance of antigenemia and persisted thereafter. These CD8+ lymphocytes in lymph nodes had increased expression of both major histocompatibility complex class II and the adhesion molecule LFA-1; they also demonstrated decreased expression of the naive T-cell-associated CD45RA molecule. SIVmac-specific cytotoxic T-lymphocyte precursors were detected in both blood and lymph node by 7 days post-virus inoculation. These studies indicate that both virus-specific humoral and cellular immune mechanisms in blood and lymph node are associated with the clearance of viremia that occurs within the first month of infection of rhesus monkeys with SIVmac.
MeSH Terms
Animals
Antibodies, Viral/blood
Antigens, Viral/blood
CD8 Antigens/immunology
Gene Products, gag/blood,immunology
Immunophenotyping
Lymph Nodes/immunology
Lymphocytosis
Macaca/microbiology
Macaca mulatta/immunology
RNA, Viral/blood
Simian Acquired Immunodeficiency Syndrome/immunology
Simian Immunodeficiency Virus/immunology
Species Specificity
T-Lymphocyte Subsets/immunology
T-Lymphocytes, Cytotoxic/immunology
Time Factors
Chemicals
Antibodies, Viral
Antigens, Viral
CD8 Antigens
Gag protein p27, Simian immunodeficiency virus
Gene Products, gag
RNA, Viral
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Reimann K A
New England Regional Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772.
Tenner-Racz K
Racz P
Montefiori D C
Yasutomi Y
Lin W
Ransil B J
Letvin N L
References (22)
22 references, click to expand
-
Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion.
Lancet. 1985 Mar 9;1(8428):537-40
PMID: 2857899
-
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.
Nature. 1993 Mar 25;362(6418):359-62
PMID: 8096068
-
Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay.
J Clin Microbiol. 1988 Feb;26(2):231-5
PMID: 3422647
-
Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection.
J Virol. 1988 Aug;62(8):3073-6
PMID: 2839723
-
Immunohistochemical, electron microscopic and in situ hybridization evidence for the involvement of lymphatics in the spread of HIV-1.
AIDS. 1988 Aug;2(4):299-309
PMID: 3140835
-
Expression of RNA and antigens of human immunodeficiency virus type-1 (HIV-1) in lymph nodes from HIV-1 infected individuals.
Am J Pathol. 1988 Dec;133(3):516-24
PMID: 3059804
-
A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.
J Exp Med. 1989 Apr 1;169(4):1421-34
PMID: 2784486
-
The simian immunodeficiency viruses.
Annu Rev Immunol. 1990;8:557-78
PMID: 2188674
-
CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity.
Proc Natl Acad Sci U S A. 1990 Jun;87(12):4818-22
PMID: 2112749
-
Animal models for AIDS.
Immunol Today. 1990 Sep;11(9):322-6
PMID: 2206278
-
High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.
N Engl J Med. 1991 Apr 4;324(14):954-60
PMID: 1900576
-
Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.
N Engl J Med. 1991 Apr 4;324(14):961-4
PMID: 1823118
-
Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys.
J Immunol. 1991 Jul 1;147(1):320-9
PMID: 1711081
-
Primary HIV infection: host responses and intervention strategies.
AIDS. 1991 Jan;5(1):1-14
PMID: 1812848
-
An activated CD8+ lymphocyte appears in lymph nodes of rhesus monkeys early after infection with simian immunodeficiency virus.
J Clin Invest. 1991 Oct;88(4):1113-20
PMID: 1717508
-
Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA.
J Infect Dis. 1991 Dec;164(6):1051-7
PMID: 1955708
-
Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells.
Am J Pathol. 1992 Jan;140(1):15-22
PMID: 1530997
-
Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge.
Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2175-9
PMID: 1549578
-
Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?
Lancet. 1992 Nov 21;340(8830):1257-8
PMID: 1359323
-
Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.
J Virol. 1993 Mar;67(3):1707-11
PMID: 8437240
-
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.
Nature. 1993 Mar 25;362(6418):355-8
PMID: 8455722
-
The role of complement and its receptor in the elimination of immune complexes.
N Engl J Med. 1986 Aug 21;315(8):488-95
PMID: 2942776